Russell Investments Group
APYX icon

Russell Investments Group’s Apyx Medical APYX Stock Holding History

Russell Investments Group’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117 Hold
26
– – ﹤0.01% 4261
2026
Q1 		$96 Buy
+26
New +$97 ﹤0.01% 4153
2022
Q3 		– Sell
-71,383
Closed -$418K – 2900
2022
Q2 		$418K Buy
71,383
+33,503
+88% +$172K ﹤0.01% 2329
2022
Q1 		$247K Sell
37,880
-117,041
-76% -$1.15M ﹤0.01% 2419
2021
Q4 		$1.98M Buy
154,921
+12,263
+9% +$172K ﹤0.01% 1807
2021
Q3 		$1.97M Buy
142,658
+13,928
+11% +$147K ﹤0.01% 1836
2021
Q2 		$1.33M Buy
128,730
+889
+0.7% +$8.81K ﹤0.01% 2167
2021
Q1 		$1.23M Buy
127,841
+45,114
+55% +$451K ﹤0.01% 2155
2020
Q4 		$594K Buy
82,727
+44,847
+118% +$297K ﹤0.01% 2356
2020
Q3 		$178K Buy
+37,880
New +$188K ﹤0.01% 2808
2020
Q1 		– Sell
-54,166
Closed -$458K – 3026
2019
Q4 		$458K Buy
+54,166
New +$391K ﹤0.01% 2430
2018
Q3 		– Sell
-114,508
Closed -$498K – 2945
2018
Q2 		$498K Buy
+114,508
New +$422K ﹤0.01% 2393

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Russell Investments Group's APYX Position: Q2 2026 in Review

Russell Investments Group held its Apyx Medical (APYX) position steady in Q2 2026 at 26 shares worth $117. The position accounts for ﹤0.01% of the portfolio, ranked #4261.

Russell Investments Group first reported a position in APYX in Q2 2018 and has held it in 12 quarters since. The position peaked at $1.98M in Q4 2021. 67 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Russell Investments Group held 26 shares of Apyx Medical worth $117 as of Q2 2026.
  • Russell Investments Group left its Apyx Medical share count unchanged in Q2 2026.
  • Apyx Medical made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #4261 holding.
  • Russell Investments Group first reported a position in Apyx Medical in Q2 2018 and has held it in 12 quarters since.
  • Russell Investments Group's Apyx Medical position peaked at $1.98M in Q4 2021.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.